Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration. | Nat Commun | 2025 | 39979261 | PubTator, text mining | PubMed |
| Multiple kinesins speed up cargo transport in crowded environments by sharing load. | Commun Biol | 2025 | 39948212 | PubTator, text mining | PubMed |
| Assessment of Exhaled Breath Condensate for ALK, RET, ROS1, and NTRK1 Fusion Transcript Detection in NSCLC: Comparison With Tissue and Liquid Biopsy Samples. | Thorac Cancer | 2025 | 39810398 | PubTator, text mining | PubMed |
| RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. | Cancer Lett | 2025 | 39800214 | PubTator, text mining | PubMed |
| [Characteristics of RET gene rearrangement detected by fluorescence in situ hybridization in lung cancer]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 39762169 | PubTator, text mining | PubMed |
| Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. | J Med Chem | 2025 | 39723919 | PubTator, text mining | PubMed |
| Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. | Neoplasia | 2025 | 39709702 | PubTator, text mining | PubMed |
| The gE/gI complex is necessary for kinesin-1 recruitment during alphaherpesvirus egress from neurons. | J Virol | 2025 | 39651860 | PubTator, text mining | PubMed |
| Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia. | Eur J Hum Genet | 2025 | 39506047 | PubTator, text mining | PubMed |
| Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models. | Brain | 2025 | 39478664 | PubTator, text mining | PubMed |
| Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular Carcinoma. | Curr Gene Ther | 2025 | 39248070 | PubTator, text mining | PubMed |
| Glucose-stimulated KIF5B-driven microtubule sliding organizes microtubule networks in pancreatic β cells. | bioRxiv | 2025 | 37425827 | PubTator, text mining | PubMed |
| Highlighting the hidden: monitoring the avidity-driven association of a fluorescent GABARAP tandem with microtubules in living cells. | Autophagy Rep | 2024 | 40395516 | PubTator, text mining | PubMed |
| Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report. | Front Pharmacol | 2024 | 40083593 | PubTator, text mining | PubMed |
| Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case. | Front Oncol | 2024 | 39882443 | PubTator, text mining | PubMed |
| A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma. | Curr Oncol | 2024 | 39590120 | PubTator, text mining | PubMed |
| Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations. | JCO Precis Oncol | 2024 | 39576953 | PubTator, text mining | PubMed |
| Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC). | BMC Pulm Med | 2024 | 39497173 | PubTator, text mining | PubMed |
| Tail-anchored membrane protein SLMAP3 is essential for targeting centrosomal proteins to the nuclear envelope in skeletal myogenesis. | Open Biol | 2024 | 39378988 | PubTator, text mining | PubMed |
| Mechanisms for assembly of the nucleoplasmic reticulum. | Cell Mol Life Sci | 2024 | 39367888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=5